A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer

被引：0
|
作者：
Li, Y. [1 ]
Xing, L. [1 ]
Yin, X. [1 ]
Li, H. [1 ]
Ren, G. [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
    Li, Yunhai
    Xing, Lei
    Li, Fan
    Liu, Hong
    Gan, Lu
    Yang, Dejuan
    Wang, Mengxue
    Yin, Xuedong
    Li, Hongyuan
    Ren, Guosheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Yuanfang Xin
    Guoshuang Shen
    Yonghui Zheng
    Yumei Guan
    Xingfa Huo
    Jinming Li
    Dengfeng Ren
    Fuxing Zhao
    Zhen Liu
    Zitao Li
    Jiuda Zhao
    BMC Cancer, 21
  • [3] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Xin, Yuanfang
    Shen, Guoshuang
    Zheng, Yonghui
    Guan, Yumei
    Huo, Xingfa
    Li, Jinming
    Ren, Dengfeng
    Zhao, Fuxing
    Liu, Zhen
    Li, Zitao
    Zhao, Jiuda
    BMC CANCER, 2021, 21 (01)
  • [4] Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis
    Mittal, Niti
    Singh, Surjit
    Mittal, Rakesh
    Kaushal, Jyoti
    Kaushal, Vivek
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1754 - +
  • [5] Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Sternschuss, Michal
    Yerushalmi, Rinat
    Saleh, Ramy R.
    Amir, Eitan
    Goldvaser, Hadar
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (11) : 3369 - 3379
  • [6] Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Michal Sternschuss
    Rinat Yerushalmi
    Ramy R. Saleh
    Eitan Amir
    Hadar Goldvaser
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3369 - 3379
  • [7] Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Ji, Qiao
    Ding, Jingxian
    Hao, Meiqi
    Luo, Nachuan
    Huang, Jiabing
    Zhang, Wenxiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
    Li, Yunhai
    Yang, Dejuan
    Chen, Ping
    Yin, Xuedong
    Sun, Jiazheng
    Li, Hongzhong
    Ren, Guosheng
    AGING-US, 2019, 11 (16): : 6286 - 6311
  • [9] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [10] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
    Zhang, Wei
    Li, Emma
    Wang, Lily
    Lehmann, Brian D. D.
    Chen, X. Steven
    CANCERS, 2023, 15 (08)
12345